Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Adamis Pharmaceuticals Corp (CLGY)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Adamis Pharmaceuticals Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 887247.
Total stock buying since 2014: $188,800.
Total stock sales since 2014: $1,753,088.
Total stock option exercises since 2014: $0.
Table 3. Detailed insider trading at Adamis Pharmaceuticals Corp (CLGY)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2022-05-25 | Carlo Dennis J Phd | Option Ex | 250,000 | .00 | 0 |
| 2022-03-18 | Benedicto David C. (Chief Financial Officer) | Sale | 3,603 | .61 | 2,208 |
| 2022-03-18 | Moss Ronald B. (Chief Medical Officer) | Sale | 8,199 | .60 | 4,952 |
| 2022-03-18 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 11,859 | .60 | 7,115 |
| 2022-03-18 | Carlo Dennis J Phd (President & CEO) | Sale | 10,490 | .60 | 6,283 |
| 2021-12-01 | Benedicto David C. (Chief Financial Officer) | Sale | 13,554 | .79 | 10,639 |
| 2021-12-01 | Moss Ronald B. (Chief Medical Officer) | Sale | 35,553 | .79 | 27,909 |
| 2021-12-01 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 50,757 | .79 | 39,844 |
| 2021-12-01 | Carlo Dennis J Phd (President & CEO) | Sale | 47,870 | .79 | 37,577 |
| 2021-02-21 | Moss Ronald B. (Chief Medical Officer) | Option Ex | 13,911 | .00 | 0 |
| 2021-02-21 | Marguglio David J. (SVP and Chief Business Officer) | Option Ex | 22,258 | .00 | 0 |
| 2021-02-21 | Hopkins Robert O (Chief Financial Officer) | Option Ex | 22,258 | .00 | 0 |
| 2021-02-21 | Carlo Dennis J Phd (President & CEO) | Option Ex | 27,822 | .00 | 0 |
| 2020-11-18 | Moss Ronald B. (Chief Medical Officer) | Sale | 8,532 | .41 | 3,463 |
| 2020-11-18 | Daniels Karen K. (VP of Operations) | Sale | 5,333 | .41 | 2,165 |
| 2020-11-18 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 8,532 | .41 | 3,463 |
| 2020-11-18 | Hopkins Robert O (Chief Financial Officer) | Sale | 7,229 | .41 | 2,934 |
| 2020-11-18 | Carlo Dennis J Phd (President & CEO) | Sale | 10,665 | .41 | 4,329 |
| 2020-09-29 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 20,000 | .80 | 16,000 |
| 2020-09-29 | Hopkins Robert O (Chief Financial Officer) | Sale | 20,000 | .80 | 16,000 |
| 2020-08-18 | Moss Ronald B. (Chief Medical Officer) | Sale | 8,749 | .87 | 7,646 |
| 2020-08-18 | Daniels Karen K. (VP of Operations) | Sale | 5,480 | .87 | 4,789 |
| 2020-08-18 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 8,749 | .87 | 7,646 |
| 2020-08-18 | Hopkins Robert O (Chief Financial Officer) | Sale | 7,418 | .87 | 6,483 |
| 2020-08-18 | Carlo Dennis J Phd (President & CEO) | Sale | 10,929 | .87 | 9,551 |
| 2020-05-19 | Daniels Karen K. (VP of Operations) | Sale | 4,855 | .56 | 2,718 |
| 2020-05-18 | Moss Ronald B. (Chief Medical Officer) | Sale | 7,736 | .56 | 4,332 |
| 2020-05-18 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 7,734 | .56 | 4,331 |
| 2020-05-18 | Hopkins Robert O (Chief Financial Officer) | Sale | 6,532 | .56 | 3,657 |
| 2020-05-18 | Carlo Dennis J Phd (President & CEO) | Sale | 9,913 | .56 | 5,551 |
| 2020-03-18 | Moss Ronald B. (Chief Medical Officer) | Sale | 10,337 | .34 | 3,483 |
| 2020-03-18 | Daniels Karen K. (VP of Operations) | Sale | 6,461 | .34 | 2,177 |
| 2020-03-18 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 10,337 | .34 | 3,483 |
| 2020-03-18 | Hopkins Robert O (Chief Financial Officer) | Sale | 8,749 | .34 | 2,948 |
| 2020-03-18 | Carlo Dennis J Phd (President & CEO) | Sale | 10,645 | .34 | 3,587 |
| 2020-02-24 | Moss Ronald B. (Chief Medical Officer) | Sale | 6,229 | .06 | 398 |
| 2020-02-24 | Daniels Karen K. (VP of Operations) | Sale | 6,229 | .60 | 3,762 |
| 2020-02-24 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 9,948 | .60 | 6,008 |
| 2020-02-24 | Hopkins Robert O (Chief Financial Officer) | Sale | 8,420 | .60 | 5,085 |
| 2020-02-24 | Carlo Dennis J Phd (President & CEO) | Sale | 12,436 | .60 | 7,511 |
| 2019-11-18 | Moss Ronald B. (Chief Medical Officer) | Sale | 8,448 | .85 | 7,197 |
| 2019-11-18 | Daniels Karen K. (VP of Operations) | Sale | 5,421 | .83 | 4,499 |
| 2019-11-18 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 8,283 | .87 | 7,197 |
| 2019-11-18 | Hopkins Robert O (Chief Financial Officer) | Sale | 7,347 | .83 | 6,098 |
| 2019-11-18 | Carlo Dennis J Phd (President & CEO) | Sale | 10,760 | .84 | 8,995 |
| 2019-08-19 | Moss Ronald B. (Chief Medical Officer) | Sale | 8,383 | 1.06 | 8,894 |
| 2019-08-19 | Daniels Karen K. (VP of Operations) | Sale | 5,243 | 1.06 | 5,557 |
| 2019-08-19 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 8,109 | 1.10 | 8,887 |
| 2019-08-19 | Hopkins Robert O (Chief Financial Officer) | Sale | 7,101 | 1.06 | 7,534 |
| 2019-08-19 | Carlo Dennis J Phd (President & CEO) | Sale | 10,477 | 1.06 | 11,116 |
| 2019-05-24 | Denby William C | Buy | 6,250 | 1.60 | 10,000 |
| 2019-05-24 | Rothermel Robert B | Buy | 6,500 | 1.58 | 10,270 |
| 2019-05-24 | Williams Richard C | Buy | 50,000 | 1.57 | 78,500 |
| 2019-05-20 | Moss Ronald B. (Chief Medical Officer) | Sale | 8,741 | 1.77 | 15,462 |
| 2019-05-20 | Daniels Karen K. (VP of Operations) | Sale | 5,591 | 1.73 | 9,672 |
| 2019-05-20 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 8,735 | 1.77 | 15,460 |
| 2019-05-20 | Hopkins Robert O (Chief Financial Officer) | Sale | 7,559 | 1.73 | 13,107 |
| 2019-05-20 | Carlo Dennis J Phd (President & CEO) | Sale | 11,184 | 1.73 | 19,337 |
| 2019-03-20 | Moss Ronald B. (Chief Medical Officer) | Sale | 6,647 | 2.27 | 15,075 |
| 2019-03-20 | Daniels Karen K. (VP of Operations) | Sale | 13,911 | 2.30 | 32,009 |
| 2019-03-20 | Marguglio David J. (SVP and Chief Business Officer) | Sale | 10,579 | 2.28 | 24,109 |
| 2019-03-20 | Hopkins Robert O (Chief Financial Officer) | Sale | 8,900 | 2.30 | 20,443 |
| 2019-03-20 | Carlo Dennis J Phd (President & CEO) | Sale | 13,292 | 2.27 | 30,132 |
| 2019-02-21 | Moss Ronald B. (Chief Medical Officer) | Option Ex | 13,911 | .00 | 0 |
| 2019-02-21 | Daniels Karen K. (VP of Operations) | Option Ex | 13,911 | .00 | 0 |
| 2019-02-21 | Marguglio David J. (SVP and Chief Business Officer) | Option Ex | 22,258 | .00 | 0 |
| 2019-02-21 | Hopkins Robert O (Chief Financial Officer) | Option Ex | 22,258 | .00 | 0 |
| 2019-02-21 | Carlo Dennis J Phd (President & CEO) | Option Ex | 27,822 | .00 | 0 |
| 2016-06-02 | Marguglio David J. (SR. VP of Corporate Devel.) | Sale | 700 | 9.00 | 6,301 |
| 2016-05-16 | Marguglio David J. (SR VP OF CORPORATE DEVELOPMENT) | Sale | 4,000 | 8.09 | 32,340 |
| 2016-05-09 | Marguglio David J. (SR VP of Corporate Development) | Sale | 4,860 | 10.00 | 48,600 |
| 2016-05-03 | Marguglio David J. (SR VP of Corporate Development) | Sale | 1,140 | 9.00 | 10,260 |
| 2016-04-14 | Marguglio David J. (SR VP of Corporate Development) | Sale | 12,000 | 7.52 | 90,216 |
| 2015-08-14 | Rothermel Robert B | Buy | 2,000 | 3.40 | 6,800 |
| 2015-08-13 | Rothermel Robert B | Buy | 5,000 | 3.30 | 16,495 |
| 2015-08-13 | Williams Richard C | Buy | 9,800 | 3.26 | 31,928 |
| 2015-04-20 | Marguglio David J. (Sr VP of Business Development) | Sale | 200 | 5.00 | 1,000 |
| 2015-04-17 | Marguglio David J. (Sr VP of Business Development) | Sale | 100 | 5.01 | 501 |
| 2015-04-16 | Marguglio David J. (Sr VP of Business Development) | Sale | 700 | 5.00 | 3,500 |
| 2015-04-14 | Marguglio David J. (Sr VP of Business Development) | Sale | 100 | 5.00 | 500 |
| 2015-04-13 | Marguglio David J. (Sr VP of Business Development) | Sale | 2,100 | 5.01 | 10,525 |
| 2015-03-04 | Marguglio David J. (Sr VP of Business Development) | Sale | 11,800 | 7.09 | 83,662 |
| 2015-03-02 | Marguglio David J. (Sr VP of Business Development) | Sale | 7,000 | 6.45 | 45,150 |
| 2015-02-13 | Eses Holdings (fze) | Sale | 12,076 | 6.41 | 77,395 |
| 2015-02-12 | Eses Holdings (fze) | Sale | 23,000 | 6.40 | 147,223 |
| 2015-02-11 | Eses Holdings (fze) | Sale | 10,000 | 6.40 | 64,000 |
| 2015-02-10 | Eses Holdings (fze) | Sale | 5,000 | 6.39 | 31,945 |
| 2015-02-03 | Eses Holdings (fze) | Sale | 20,000 | 6.67 | 133,380 |
| 2015-01-30 | Eses Holdings (fze) | Sale | 10,000 | 6.92 | 69,170 |
| 2015-01-08 | Marguglio David J. (Sr VP of Business Development) | Sale | 200 | 7.00 | 1,400 |
| 2015-01-05 | Marguglio David J. (Senior VP of Bus. Development) | Sale | 7,000 | 6.18 | 43,260 |
| 2014-12-30 | Marguglio David J. (Sr VP of Business Development) | Sale | 12,228 | 6.09 | 74,468 |
| 2014-12-29 | Marguglio David J. (Senior VP of Bus. Development) | Sale | 772 | 6.00 | 4,632 |
| 2014-12-12 | Marguglio David J. (Sr VP of Business Development) | Sale | 4,000 | 5.18 | 20,740 |
| 2014-09-02 | Marguglio David J. (Sr VP of Business Development) | Sale | 8,000 | 5.06 | 40,472 |
| 2014-09-02 | Denby William C | Buy | 2,500 | 5.06 | 12,642 |
| 2014-08-29 | Rothermel Robert B | Buy | 5,500 | 4.03 | 22,165 |
| 2014-06-09 | Eses Holdings (fze) | Sale | 26,585 | 5.24 | 139,385 |
| 2014-06-02 | Marguglio David J. (Sr VP of Business Development) | Sale | 4,000 | 5.56 | 22,256 |
Insider trading activities including stock purchases, stock sales, and option exercises
of CLGY listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Adamis Pharmaceuticals Corp (symbol CLGY,
CIK number 887247) see
the Securities and Exchange Commission (SEC) website.